Increasing Your Mounjaro Dose: What Changes and Why

You've finished your first pen and the question everyone asks: is it working yet?

Picture this: four weeks in on 2.5 mg, you've had a bit of nausea in the first week, it's mostly passed, and the scale has barely moved. You're wondering whether this is even doing anything. This is exactly the situation the titration schedule is designed for. The first pen's job is adjustment, not transformation. The dual GIP and GLP-1 receptors that tirzepatide targets (the mechanism that slows gastric emptying and quiets appetite signals) respond more robustly as the dose climbs. At 2.5 mg, your system is learning to tolerate the medicine. Real appetite suppression tends to become more noticeable from 5 mg onwards, which is why stepping up after four weeks is standard practice.

The full Mounjaro treatment overview explains the mechanism in more detail, but the short version is this: the higher the dose, the stronger the satiety signal your gut sends to your brain after meals. That's not the same as saying the highest dose is always the right destination, some people find a middle dose hits the balance they need.

One practical note on timing: if your four-week mark lands on a bank holiday or you're mid-holiday yourself, order ahead. The 12pm cut-off for same-day dispatch is there every Monday to Friday, so a little planning keeps the schedule on track.

What each dose increase actually does (and why side effects often briefly return

Stepping from one strength to the next) say, from 5 mg to 7.5 mg, is a meaningful pharmacological change. The medicine's appetite-suppressing and blood-sugar-regulating effects both intensify, which is precisely what increased doses are shown to produce in terms of weight loss. In the SURMOUNT-1 trial involving over 2,500 adults, the highest dose group (15 mg, 72 weeks) saw an average body weight reduction of around 20 to 21 percent, substantially more than lower doses achieved, a clear signal that dose matters. The trial results are detailed in the SURMOUNT-1 paper in the New England Journal of Medicine.

The trade-off is a temporary return of side effects. Nausea, loose stools, or reflux that had settled at your previous dose can reappear for a week or two after stepping up. This happens because your gut is readjusting to a new level of GLP-1 and GIP stimulation. It is not a reason to stop. For most people, these symptoms ease again within a fortnight, just as they did the first time. Eating smaller portions, prioritising protein, and staying well hydrated can all help, and if you want to get every last unit from your current pen before moving up, our guide on how to extract the golden dose from a Mounjaro pen is worth a read. For a fuller picture of what to expect, the guide to side effects when increasing dose covers this in detail.

The NHS tirzepatide information page lists the full side effect profile and notes which symptoms warrant prompt medical advice, including severe or persistent abdominal pain that radiates to the back, which should always be assessed by a clinician.

When your prescriber decides it's time to move up, and when they might not

Dose increases are never automatic. At nume (sorry, at our pharmacy) every repeat order triggers a fresh clinical review by a GPhC-registered prescriber before anything is dispensed. That review looks at how your current dose is sitting with you, whether your weight loss is on track, and whether there are any side effects that need addressing first. Rushing up the ladder is not the goal; arriving at the right dose is.

There are situations where a prescriber will recommend staying at a given dose longer before moving up: persistent nausea that hasn't settled, a recent illness, or a clinical picture that suggests more time at the current level is the better call. There are also situations where the conversation goes the other way and someone stays at, say, 10 mg rather than pushing to 15 mg because the results and tolerability are both good. The reasons why dose increases are recommended and the benefits they can bring are worth reading alongside this page.

It is also worth knowing that tirzepatide is shared across the same licensed UK supply chain whether it is prescribed for weight management or type 2 diabetes. The 5 mg strength, like every other, is a prescription-only medicine. A prescriber who knows your case decides whether an increase is the right next step, no exceptions.

Mounjaro price across doses: does the cost change as you step up?

This is a question the Mounjaro pricing page answers properly, but the short answer is yes, higher strength pens typically cost more through private providers, which reflects the licensed supply chain. That gap widened meaningfully after Eli Lilly raised UK list prices from September 2025, with the highest-dose pen's list price rising considerably. Any legitimate provider's price will include clinical assessment, prescription, and dispensing; if a price looks unusually low or comes with a discount code attached, that is a flag, not a deal. For a prescription medicine, the right question is whether the supply is genuine and the prescribing is safe, not which listing is cheapest.

If you are considering starting treatment or are already on it and want to understand your options as doses increase, checking your eligibility with our prescribers costs nothing and takes a few minutes. Every consultation is reviewed personally on the same day.